1. Centers for Disease Control and Prevention. An Update of Cancer Deaths in the United States. 2021. Available at: https://www.cdc.gov/cancer/dcpc/research/update-on-cancer-deaths/index.htm#:~:text=What%20were%20the%20leading%20causes,intrahepatic%20bile%20duct%20(5%25). Accessed 10 Feb 2022.
2. American Cancer Society. Survival Rates for Pancreatic Cancer. Available at: https://www.cancer.org/cancer/pancreatic-cancer/detection-diagnosis-staging/survival-rates.html. Published 2021. Accessed 10 Feb 2022.
3. Steinberg W. The clinical utility of the CA 19–9 tumor-associated antigen. Am J Gastroenterol. 1990;85(4):350–5.
4. Tempero MA, Uchida E, Takasaki H, Burnett DA, Steplewski Z, Pour PM. Relationship of carbohydrate antigen 19–9 and Lewis antigens in pancreatic cancer. Cancer Res. 1987;47(20):5501–3.
5. Dumitra S, Jamal MH, Aboukhalil J, et al. Pancreatic cancer and predictors of survival: comparing the CA 19–9/bilirubin ratio with the McGill Brisbane Symptom Score. HPB (Oxford). 2013;15(12):1002–9.